S. Levak-Frank, et.al., Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice., The Journal of clinical investigation, 1995, 96

http://rdf.ncbi.nlm.nih.gov/pubmed/7635990

S. Levak-Frank, et.al., Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice., The Journal of clinical investigation, 1995, 96

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(Ckm-LPL)LRze
  http://metadb.riken.jp/db/mgi_rdf/MGI:3624976
• Tg(Ckm-LPL)HRze
  http://metadb.riken.jp/db/mgi_rdf/MGI:3624978
• Tg(Ckm-LPL)MRze
  http://metadb.riken.jp/db/mgi_rdf/MGI:3624977

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased skeletal muscle glycogen level_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0010401IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• weight loss_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0001263IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• weight loss_Tg(Ckm-LPL)LRze/0
  http://metadb.riken.jp/0001263IC57BL6JCBAJTgCkmLPLLRze0TgCkmLPLLRze
• increased catalase activity_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0011593IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• abnormal myocardial fiber morphology_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0000278IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• decreased circulating VLDL triglyceride level_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0003976IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• decreased skeletal muscle mass_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0004819IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• abnormal myocardial fiber morphology_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0000278IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• premature death_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0002083IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• decreased circulating triglyceride level_Tg(Ckm-LPL)LRze/0
  http://metadb.riken.jp/0002644IC57BL6JCBAJTgCkmLPLLRze0TgCkmLPLLRze
• increased muscle free fatty acid level_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0003249IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• weight loss_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0001263IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• abnormal muscle fiber morphology_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0004087IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• decreased body weight_Tg(Ckm-LPL)LRze/0
  http://metadb.riken.jp/0001262IC57BL6JCBAJTgCkmLPLLRze0TgCkmLPLLRze
• abnormal adipose tissue distribution_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0000013IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• abnormal skeletal muscle morphology_Tg(Ckm-LPL)LRze/0
  http://metadb.riken.jp/0000759IC57BL6JCBAJTgCkmLPLLRze0TgCkmLPLLRze
• myopathy_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0000751IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• decreased circulating VLDL triglyceride level_Tg(Ckm-LPL)LRze/0
  http://metadb.riken.jp/0003976IC57BL6JCBAJTgCkmLPLLRze0TgCkmLPLLRze
• abnormal muscle fiber morphology_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0004087IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• decreased body weight_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0001262IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• abnormal enzyme/coenzyme activity_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0005584IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• increased catalase activity_Tg(Ckm-LPL)LRze/0
  http://metadb.riken.jp/0011593IC57BL6JCBAJTgCkmLPLLRze0TgCkmLPLLRze
• premature death_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0002083IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• myopathy_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0000751IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• decreased body weight_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0001262IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• decreased circulating triglyceride level_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0002644IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• increased skeletal muscle glycogen level_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0010401IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• abnormal skeletal muscle morphology_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0000759IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• decreased circulating VLDL triglyceride level_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0003976IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• abnormal skeletal muscle morphology_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0000759IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• abnormal adipose tissue distribution_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0000013IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• decreased circulating triglyceride level_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0002644IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• increased catalase activity_Tg(Ckm-LPL)MRze/0
  http://metadb.riken.jp/0011593IC57BL6JCBAJTgCkmLPLMRze0TgCkmLPLMRze
• increased muscle free fatty acid level_Tg(Ckm-LPL)HRze/0
  http://metadb.riken.jp/0003249IC57BL6JCBAJTgCkmLPLHRze0TgCkmLPLHRze
• premature death_Tg(Ckm-LPL)LRze/0
  http://metadb.riken.jp/0002083IC57BL6JCBAJTgCkmLPLLRze0TgCkmLPLLRze

class

http://purl.org/net/cito/citesAsAuthority

• Tg(Ckm-LPL)LRze
  http://metadb.riken.jp/db/mgi_rdf/MGI:3624976
• Tg(Ckm-LPL)HRze
  http://metadb.riken.jp/db/mgi_rdf/MGI:3624978
• Tg(Ckm-LPL)MRze
  http://metadb.riken.jp/db/mgi_rdf/MGI:3624977